calendar
2,354 catalysts · 4,876 phase readout · 2,347 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion
2,354 catalysts · 4,876 phase readout · 2,347 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion
Items: 7.01, 9.01
Items: 8.01, 9.01
Items: 1.01, 8.01, 9.01
Items: 8.01, 9.01
Items: 1.01, 2.02, 7.01, 8.01, 9.01
Items: 8.01
Items: 2.02, 9.01
Items: 5.02
Items: 1.01, 7.01, 9.01
Items: 5.02
Items: 5.02
Items: 5.02
Items: 2.02, 9.01
Items: 7.01, 8.01, 9.01
Items: 8.01
Items: 8.01, 9.01
Items: 1.01, 8.01, 9.01
Items: 1.01, 8.01, 9.01
Items: 7.01, 9.01
Items: 1.01, 2.01, 9.01
Items: 1.01, 8.01, 9.01
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.
Items: 8.01, 9.01
Items: 2.02, 9.01
Items: 5.02, 7.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 7.01, 9.01
Items: 7.01, 9.01
Items: 1.01, 3.03, 8.01, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 8.01
Items: 2.02, 7.01, 9.01
Items: 5.02
Items: 2.02, 9.01
Items: 1.01, 9.01
Items: 5.02, 8.01, 9.01
Items: 8.01
Items: 1.01, 7.01, 9.01
Items: 3.01
Items: 5.02, 9.01
Items: 3.01, 9.01
Items: 7.01, 9.01
Items: 5.02
Items: 5.07
Items: 5.02
Items: 5.07
Items: 1.01, 5.01, 7.01, 9.01
Items: 5.02
Items: 7.01, 9.01